| Dear Reader, We’ve taken some time and deliberation here. But we’re finally ready to start pulling the trigger on some calculated speculations on artificial intelligence. We’re being careful not to join the bandwagon, though. Which is why our focus is on a certain niche…where AI intersects with medicine. One such speculation here deserves your immediate attention. We’ve judged there are two potential outcomes for this little-known medtech. One is that it could become the next Pro Medicus, an ASX stock that went from 43 cents to $63 in 10 years. Another is that it goes largely nowhere. As, we believe, many AI stocks will end up doing while this boom plays out. Click here and make your own call. Regards, James Woodburn,
Publisher, Fat Tail Investment Research | 